GB0823493D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB0823493D0
GB0823493D0 GB0823493A GB0823493A GB0823493D0 GB 0823493 D0 GB0823493 D0 GB 0823493D0 GB 0823493 A GB0823493 A GB 0823493A GB 0823493 A GB0823493 A GB 0823493A GB 0823493 D0 GB0823493 D0 GB 0823493D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0823493A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmakodex Ltd
Original Assignee
Pharmakodex Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmakodex Ltd filed Critical Pharmakodex Ltd
Priority to GB0823493A priority Critical patent/GB0823493D0/en
Publication of GB0823493D0 publication Critical patent/GB0823493D0/en
Ceased legal-status Critical Current

Links

GB0823493A 2008-12-24 2008-12-24 Formulations Ceased GB0823493D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0823493A GB0823493D0 (en) 2008-12-24 2008-12-24 Formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0823493A GB0823493D0 (en) 2008-12-24 2008-12-24 Formulations

Publications (1)

Publication Number Publication Date
GB0823493D0 true GB0823493D0 (en) 2009-01-28

Family

ID=40344157

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0823493A Ceased GB0823493D0 (en) 2008-12-24 2008-12-24 Formulations

Country Status (1)

Country Link
GB (1) GB0823493D0 (en)

Similar Documents

Publication Publication Date Title
GB0815435D0 (en) Formulations
GB2459691B (en) Formulations
ZA201106050B (en) Dye-polymers formulations
GB0711656D0 (en) Formulations
GB0716385D0 (en) Formulations
GB0823269D0 (en) Formulations
ZA200908969B (en) Formulations
GB0821789D0 (en) Formulations
GB0711957D0 (en) Formulations
GB0919210D0 (en) Formulations
GB0809979D0 (en) Formulations
HUE054030T2 (en) Improved formulations
EP2307021A4 (en) Formulations
GB0806978D0 (en) Novel formulations
GB0822633D0 (en) Formulation
GB0810232D0 (en) Formulations
ZA201004772B (en) Novel formulation
GB0814376D0 (en) Formulation
GB0705179D0 (en) Formulations
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
IL217390A0 (en) Formulations
GB0823486D0 (en) Formulations
GB0916106D0 (en) Formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)